Search

Your search keyword '"Leen, C"' showing total 598 results

Search Constraints

Start Over You searched for: Author "Leen, C" Remove constraint Author: "Leen, C"
598 results on '"Leen, C"'

Search Results

2. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

3. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.

4. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

6. Ultrasound in Continuous Tubular Crystallizers: Parameters Affecting the Nucleation Rate

7. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

8. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

9. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

10. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

11. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

12. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

13. Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

15. Observational cohort study of rilpivirine (RPV) utilization in Europe

16. Reducing the Induction Time Using Ultrasound and High-Shear Mixing in a Continuous Crystallization Process

17. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

20. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response:a sub-study of the NEAT001/ANRS143 randomized trial

23. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

24. Agglomeration Control during Ultrasonic Crystallization of an Active Pharmaceutical Ingredient

26. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study

27. Continuous Crystallization Using Ultrasound Assisted Nucleation, Cubic Cooling Profiles and Oscillatory Flow

30. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

31. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

32. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus:Impact of Hepatitis C Virus Treatment

33. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

35. Increased case‐finding and uptake of direct‐acting antiviral treatment essential for micro‐elimination of hepatitis C among people living with HIV: a national record linkage study

36. Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

40. Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK

45. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

50. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

Catalog

Books, media, physical & digital resources